MPM BIOVENTURES 2018, L.P. sold TRDA
August 31, 2026 · Form 4 insider transaction
MPM BIOVENTURES 2018, L.P. sold 44,259 shares of Entrada Therapeutics, Inc. at $6.99 per share, a transaction worth $309.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The shares were sold as follows: 20,097 by BV 2014, 1,341 by BV 2014(B), 692 by AM BV2014, 20,626 by BV 2018, 1,096 by BV 2018(B) and 407 by AM BV2018.; Price represents the weighted average sale price of the shares sold. The sale price ranged from $6.76 to $7.1626 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.; Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.; The shares are held as follows: 1,921,425 by BV 2014, 128,155 by BV 2014(B), 66,136 by AM BV2014, 1,971,989 by BV 2018, 104,809 by BV 2018(B) and 38,920 by AM BV2018.